Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
JNJ | US
-3.15
-1.37%
Healthcare
Drug Manufacturers - Major
30/06/2024
24/04/2026
227.50
229.03
229.99
227.02
Johnson & Johnson together with its subsidiaries researches develops manufactures and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO CLEAN & CLEAR DR. CI:LABO NEUTROGENA and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold flu and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public retail outlets and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis psoriatic arthritis inflammatory bowel disease and psoriasis; HIV/AIDS infectious diseases; mood disorders neurodegenerative disorders and schizophrenia; prostate cancer hematologic malignancies lung cancer and bladder cancer; thrombosis diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers wholesalers distributors hospitals and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips knees trauma spine sports and other; advanced and general surgery solutions that focus on breast aesthetics ear nose and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers hospitals and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick New Jersey.
View LessLow 6-Month Volatility (<30%)
Megacap (>200B USD)
Good Dividend Yield (2% <= Dividend Yield <= 8%)
Low Market Beta (-0.4 to 0.8)
Strong Sharpe Ratio (> 1.2)
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
19.1%1 month
17.8%3 months
16.4%6 months
16.8%27.34
15.43
5.56
0.58
0.23
18.31
4.72
0.98
30.11B
547.65B
547.65B
3.00
23.67
-89.10
5.20
22.15
3.23
0.82
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
18.48
Range1M
23.43
Range3M
33.87
Rel. volume
0.85
Price X volume
1.31B
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| AstraZeneca PLC | AZN | Drug Manufacturers - Major | 189.75 | 588.34B | -1.33% | 37.99 | 84.87% |
| AbbVie Inc | ABBV | Drug Manufacturers - Major | 198.71 | 350.99B | -1.11% | 62.95 | 1042.11% |
| Novartis AG | NVS | Drug Manufacturers - Major | 145.47 | 294.52B | -1.36% | 23.96 | 69.46% |
| Merck & Co. Inc | MRK | Drug Manufacturers - Major | 111.9 | 283.65B | -2.37% | 20.13 | 86.71% |
| Pfizer Inc | PFE | Drug Manufacturers - Major | 27 | 153.00B | 1.24% | n/a | 79.19% |
| Bristol-Myers Squibb Company | BMY | Drug Manufacturers - Major | 58.71 | 119.03B | -0.53% | n/a | 317.39% |
| Sanofi | SNY | Drug Manufacturers - Major | 46.78 | 117.28B | -1.58% | 30.18 | 32.67% |
| GlaxoSmithKline plc | GSK | Drug Manufacturers - Major | 54.44 | 111.97B | -2.14% | 13.16 | 117.89% |
| Hutchison China MediTech Limited | HCM | Drug Manufacturers - Major | 14 | 2.39B | 0.94% | n/a | 11.09% |
| Rockwell Medical Inc | RMTI | Drug Manufacturers - Major | 0.8727 | 27.08M | 1.99% | n/a | 61.18% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Amphenol Corporation | APH | Electronic Components | 149.71 | 180.29B | -0.31% | 40.40 | 60.57% |
| Corning Incorporated | GLW | Electronic Components | 175.89 | 150.51B | 3.77% | 91.49 | 77.44% |
| TE Connectivity Ltd | TEL | Electronic Components | 214.67 | 65.24B | -1.41% | 13.34 | 33.26% |
| CBRE Group Inc | CBRE | Real Estate Services | 148.29 | 45.44B | -0.68% | 42.32 | 79.63% |
| Hubbell Incorporated | HUBB | Electronic Components | 553.07 | 29.69B | -0.86% | 33.79 | 70.46% |
| nVent Electric plc | NVT | Electronic Components | 142.17 | 23.63B | -0.27% | 22.02 | 57.48% |
| KE Holdings Inc | BEKE | Real Estate Services | 16.18 | 20.57B | 2.41% | 42.20 | 28.64% |
| Jones Lang LaSalle Incorporated | JLL | Real Estate Services | 338.56 | 16.07B | 0.28% | 33.62 | 58.74% |
| CoStar Group Inc | CSGP | Real Estate Services | 36.44 | 14.93B | -2.51% | 152.40 | 14.68% |
| Advanced Energy Industries Inc | AEIS | Electronic Components | 387.24 | 14.59B | 1.25% | 44.72 | 87.62% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 18.31 | 21.06 | Par |
| Ent. to Revenue | 4.72 | 5.64 | Par |
| PE Ratio | 27.34 | 41.17 | Cheaper |
| Price to Book | 5.56 | 11.46 | Cheaper |
| Dividend Yield | 3.00 | 3.27 | Par |
| Std. Deviation (3M) | 16.37 | 39.12 | Lower Risk |
| Debt to Equity | 0.58 | 1.72 | Cheaper |
| Debt to Assets | 0.23 | 0.31 | Cheaper |
| Market Cap | 547.65B | 200.67B | Market Leader |